| 0 (0%) | 10-14 18:22 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 1.47 | 1-year : | 1.83 |
| Resists | First : | 1.26 | Second : | 1.57 |
| Pivot price | 1.14  |
|||
| Supports | First : | 0.75 | Second : | 0.63 |
| MAs | MA(5) : | 1.11 |
MA(20) : | 1.16 |
| MA(100) : | 0.89 |
MA(250) : | 1.21 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 27 |
D(3) : | 29.6 |
| RSI | RSI(14): 55 |
|||
| 52-week | High : | 2.3 | Low : | 0.56 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ BGI ] has closed above bottom band by 39.7%. Bollinger Bands are 49% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.15 - 1.16 | 1.16 - 1.16 |
| Low: | 1.04 - 1.05 | 1.05 - 1.06 |
| Close: | 1.12 - 1.13 | 1.13 - 1.14 |
Sat, 11 Oct 2025
(BGI.UN) Investment Strategy and Analysis (BGI.UN:CA) - news.stocktradersdaily.com
Fri, 03 Oct 2025
OMV strengthens shareholder returns and reflects Borouge Group International transaction with adjusted shareholder distribution policy - OMV
Tue, 23 Sep 2025
BGI Genomics taps AI to power healthcare transformation in Saudi Vision - EurekAlert!
Fri, 12 Sep 2025
Chinese biotech firm MGI’s DNA sequencers gaining in the market, BGI CEO says - South China Morning Post
Fri, 22 Aug 2025
BGI-Research and Global Partners Unveil Advanced Single-Cell Technology and Launch the "10 Billion Cells Alliance" - BioSpace
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 12 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 76.6 (%) |
| Held by Institutions | 0.6 (%) |
| Shares Short | 14 (K) |
| Shares Short P.Month | 20 (K) |
| EPS | -0.19 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.28 |
| Profit Margin | -2.5 % |
| Operating Margin | 0.7 % |
| Return on Assets (ttm) | 0.3 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 17.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 16.06 |
| EBITDA (p.s.) | 0.68 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -9 (M) |
| PE Ratio | -6.28 |
| PEG Ratio | 0 |
| Price to Book value | -4.19 |
| Price to Sales | 0.07 |
| Price to Cash Flow | -76.65 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|